Si Y

ORCID: 0000-0001-7126-4941 · 3 papers in corpus
2024
Economic evaluation of GnRH-agonist long protocol and GnRH-antagonist protocol in IVT/ICSI among the Chinese population: using pharmacoeconomic models.
BMJ open ·doi:10.1136/bmjopen-2023-079715

ObjectiveThis paper uses health economics methods to discuss the cost-effectiveness value of long protocol and antagonist protocol for in vitro fertilisation and embryo transfer (ET) in the Chinese population.DesignHealth economic evaluatio…

2024
Systematic review of the economic evaluation model of assisted reproductive technology.
Health economics review ·doi:10.1186/s13561-024-00509-3

BackgroundWith the increasing demand for fertility services, it is urgent to select the most cost-effective assisted reproductive technology (ART) treatment plan and include it in medical insurance. Economic evaluation reports are an import…

2023
hUMSCs Restore Uterine Function by Inhibiting Endometrial Fibrosis via Regulation of the MMP-9/TIMP-1 Ratio in CDDP-Induced Injury Rats.
Stem cells international ·doi:10.1155/2023/8014052

The fertility of females of childbearing age who are cured of cancer by chemotherapy is gradually declining globally. As a broad-spectrum chemotherapy drug in clinic, the damage of cisplatin (CDDP) to female reproductive function cannot be …